Company to Ring Opening Bell June 14 to Bring Awareness to Addiction Treatment;
Company Will Maintain Premium Listing on London Stock Exchange
RICHMOND, Va., June 12, 2023 /PRNewswire/ -- Indivior PLC (LSE:INDV.LN), a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses, today announces that the U.S. Securities & Exchange Commission (SEC) declared its registration statement on Form 20-F effective on June 9. Trading in Indivior ordinary shares on the Nasdaq Global Select Market will commence at U.S. market open today.
Read more at prnewswire.com